---
$id: https://graph.org.ai/products/commodity/51302317
$type: Product
source: UNSPSC
code: "51302317"
title: "Sertaconazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sertaconazole

**UNSPSC Code**: 51302317
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C20H15Cl3N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 72W71I16EG, chemically known as 7-chloro-3-(1-(2,4-dichlorophenyl)-2-(1h-imidazol-1-yl)ethoxy-methyl)benzo(b)thiophene but generally known as sertaconazole, which bears US NIH Compound Identifier 65863. European Medicines Agency schedules Sertaconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10497MIG. The term SERTACONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules sertaconazole in its Anatomical Therapeutic Chemical (ATC) Classification. SERTACONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sertaconazole under HS 29349990 and SITC 51579. As of Q4 2014, SERTACONAZOLE remains the US FDA Preferred Term for this commodity. Sertaconazole bears US NLM identifiers UMLS ID C0074391 and NCI Concept Code C75206. SMILES: CLC1C(C(OCC2C3C(SC2)C(CL)CCC3)CN2CCNC2)CCC(CL)C1.

